Author

Jackson Chapman

Yale University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Bayo LauiD· 1 shared Hugo Y. K. LamiD· 1 shared Jonathan WarrelliD· 1 shared Lijing Yao· 1 shared Mark GersteiniD· 1 shared Paul Willard Merrill· 1 shared Prashant S. EmaniiD· 1 shared Tarsus Lam· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Bayo LauORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Insights from Incorporating Quantum Computing into Drug Design Workflows

Bayo Lau, Prashant S. Emani, Jackson Chapman, Lijing Yao, Tarsus Lam, Paul Willard Merrill, Jonathan Warrell, Mark Gerstein, Hugo Y. K. Lam

This paper introduces HypaCADD, a hybrid classical-quantum workflow for drug design that uses quantum machine learning to predict mutation impacts, showing performance comparable to classical methods.

Bioinformatics · Dec 7, 2022Peer-reviewedBioinformatics